Ozempic: knowledge and creativity regarding wellness and controlling type 2 diabetes (Paperback) (ISBN-13: 9798875878701)

Ozempic, a revolutionary medication in the realm of diabetes management, stands as a testament to advancements in pharmacotherapy. Developed by Novo Nordisk, this glucagon-like peptide-1 receptor agonist (GLP-1 RA) has garnered attention for its efficacy in addressing the intricate challenges associated with type 2 diabetes mellitus. Beyond its primary role in glycemic control, Ozempic unfurls additional benefits that resonate with individuals navigating the complex landscape of diabetes. Weight management emerges as a noteworthy ally, as Ozempic has demonstrated a propensity for weight loss, a welcome outcome for those contending with the intricate interplay between diabetes and obesity.

Author: Mary Williams
ISBN-10: 8875878706
ISBN-13: 9798875878701
Publisher: Independently Published
Language: English
Published: 01/12/2024
Pages: 102
Format: Paperback
Weight: 0.32lbs
Size: 9.00h x 6.00w x 0.21d